Emerging COVID-19 virus variants and low vaccination coverage in Ethiopia: The need for tailored vaccination strategy

Share:
  • Articles
  • Submited: March 23, 2022
  • Published: July 1, 2022

Abstract

The world has faced multiple waves of COVID-19 outbreaks, with more than 300 million cases and 5.5 million deaths officially reported globally as of Jan 8, 2022. Within the first year of the pandemic, there was hope that it would soon be under control, yet the pandemic sustains to be the world's priority health agenda. This brief communication provides emerging time-sensitive perspectives on the need for a tailored COVID-19 vaccination strategy in Ethiopia by reviewing studies and expert opinions. As of Jan 8, 2022, Ethiopia has reported 443,339 cases and 7,020 COVID-19-related deaths. Only 9,361,640 people (8%) of the Ethiopian population received at least one dose of the COVID-19 vaccine. While the short supply of vaccines is mentioned as a major bottleneck, the role of vaccine skepticism is largely overlooked, though the vaccine is the primary means to combat the emergence of new variants. Therefore, we recommend vaccine advocacy and awareness creation, planning for vaccine mandate for certain groups of the society, and targeted vaccination and economical use of the vaccines.

Downloads

Download data is not yet available.

References

  1. Pneumonia of unknown cause – China [Internet]. [cited 2022 Jun 6]. Available from:
  2. htps://www.who.int/emergencies/disease-outbreak-news/item/2020-DON229
  3. COVID-19 Map [Internet]. Johns Hopkins Coronavirus Resource Center. [cited 2022 Jun 6]. Available from:
  4. https://coronavirus.jhu.edu/map.html
  5. Commissioner O of the. FDA Takes Key Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for First
  6. COVID-19 Vaccine [Internet]. FDA. FDA; 2020 [cited 2022 Jun 6]. Available from: https://www.fda.gov/news-events/press-
  7. announcements/fda-takes-key-action-fight-against-covid-19-issuing-emergency-use-authorization-first-covid-19
  8. Gudina EK, Mekonnen Z, Yilma D. Vaccine Inequity and Hesitancy: A Vicious Cycle Undermining the Fight Against the
  9. COVID-19 Pandemic. Risk Manag Healthc Policy. 2022 Apr;Volume 15:865–9.
  10. Hyder AA, Hyder MA, Nasir K, Ndebele P. Inequitable COVID-19 vaccine distribution and its effects. Bull World Health
  11. Organ. 2021 Jun 1;99(6):406-406A.
  12. Janssen C, Maillard A, Bodelet C, Claudel AL, Gaillat J, Delory T, et al. Hesitancy towards COVID-19 Vaccination among
  13. Healthcare Workers: A Multi-Centric Survey in France. Vaccines. 2021 May 22;9(6):547.
  14. Paris C, Bénézit F, Geslin M, Polard E, Baldeyrou M, Turmel V, et al. COVID-19 vaccine hesitancy among healthcare workers.
  15. Infect Dis Now. 2021 Aug;51(5):484–7.
  16. Sallam M. COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates. Vaccines
  17. [Internet]. 2021 Feb [cited 2022 Jun 6];9(2). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7920465/
  18. Mutombo PN, Fallah MP, Munodawafa D, Kabel A, Houeto D, Goronga T, et al. COVID-19 vaccine hesitancy in Africa: a call
  19. to action. Lancet Glob Health. 2022 Mar;10(3):e320–1.
  20. Rana R, Tripathi A, Kumar N, Ganguly NK. A Comprehensive Overview on COVID-19: Future Perspectives. Front Cell Infect
  21. Microbiol. 2021 Sep 14;11:744903.
  22. Ritchie H, Mathieu E, Rodés-Guirao L, Appel C, Giattino C, Ortiz-Ospina E, et al. Coronavirus Pandemic (COVID-19). Our
  23. World Data [Internet]. 2020 Mar 5 [cited 2022 Jun 6]; Available from: https://ourworldindata.org/covid- vaccinations
  24. Seroprevalence of anti-SARS-CoV-2 antibodies in Africa: A systematic review and meta-analysis - PubMed [Internet].
  25. [cited 2022 Jun 6]. Available from: https://pubmed.ncbi.nlm.nih.gov/34228851/
  26. Ethiopia: WHO Coronavirus Disease (COVID-19) Dashboard With Vaccination Data [Internet]. [cited 2022 Jun 6]. Available
  27. from: https://covid19.who.int
  28. Oromia Health Bureau. COVID-19 [Internet]. Available from: https://www.orhb.gov.et/covid-19-2/
  29. Mulu A, Bekele A, Abdissa A, Balcha TT, Habtamu M, Mihret A, et al. The challenges of COVID-19 testing in Africa: the
  30. Ethiopian experience. Pan Afr Med J. 2021;38:6.
  31. Gudina EK, Ali S, Girma E, Gize A, Tegene B, Hundie GB, et al. Seroepidemiology and model-based prediction of SARS-
  32. CoV-2 in Ethiopia: longitudinal cohort study among frontline hospital workers and communities. Lancet Glob Health. 2021
  33. Nov;9(11):e1517–27.
  34. Thompson MG, Stenehjem E, Grannis S, Ball SW, Naleway AL, Ong TC, et al. Effectiveness of Covid-19 Vaccines in
  35. Ambulatory and Inpatient Care Settings. N Engl J Med. 2021 Oct 7;385(15):1355–71.
  36. Mohammed R, Nguse TM, Habte BM, Fentie AM, Gebretekle GB. COVID-19 vaccine hesitancy among Ethio pian
  37. healthcare workers. PLOS ONE. 2021 Dec 17;16(12):e0261125.
  38. Aemro A, Amare NS, Shetie B, Chekol B, Wassie M. Determinants of COVID-19 vaccine hesitancy among health care
  39. workers in Amhara region referral hospitals, Northwest Ethiopia: a cross-sectional study. Epidemiol Infect [Internet]. 2021
  40. ed [cited 2022 Jun 6];149. Available from: https://www.cambridge.org/core/journals/epidemiology-and-
  41. infection/article/determinants-of-covid19-vaccine-hesitancy-among-health-care-workers-in-amhara-region-referral-
  42. hospitals-northwest-ethiopia-a-crosssectional-study/A8D37F568D0630142F3D407F4A95E5BD
  43. Yilma D, Mohammed R, Abdela SG, Enbiale W, Seifu F, Pareyn M, et al. COVID-19 vaccine acceptability among
  44. healthcare workers in Ethiopia: Do we practice what we preach? Trop Med Int Health. 2022;27(4):418–25.
  45. Cantón R, De Lucas Ramos P, García-Botella A, García-Lledó A, Gómez-Pavón J, González del Castillo J, et al. New variants
  46. of SARS-CoV-2. Rev Esp Quimioter. 2021 Oct 25;34(5):419–28.
  47. Eyre DW, Taylor D, Purver M, Chapman D, Fowler T, Pouwels KB, et al. The impact of SARS-CoV-2 vaccination on Alpha
  48. & Delta variant transmission [Internet]. medRxiv; 2021 [cited 2022 Jun 6]. p. 2021.09.28.21264260. Available from:
  49. https://www.medrxiv.org/content/10.1101/2021.09.28.21264260v1
  50. Andrews N, Stowe J, Kirsebom F, Toffa S, Rickeard T, Gallagher E, et al. Effectiveness of COVID-19 vaccines against the
  51. Omicron (B.1.1.529) variant of concern [Internet]. medRxiv; 2021 [cited 2022 Jun 6]. p. 2021.12.14.21267615. Available
  52. from: https://www.medrxiv.org/content/10.1101/2021.12.14.21267615v1
How to Cite
Gudina, E. K. ., Yilma, D. ., Degfie, T., Yakob, B., Serbessa, T. ., Gobena, D. ., Girma, T. ., & Mekonnen, Z. (2022). Emerging COVID-19 virus variants and low vaccination coverage in Ethiopia: The need for tailored vaccination strategy . Ethiopian Medical Journal, 60(3). Retrieved from https://www.emjema.org/index.php/EMJ/article/view/2122

Send mail to Author


Send Cancel